Research / ROKU / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-054335 General Corporate
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.28% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.01% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
21.93% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
8.59% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
49.73% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
10.79% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.26% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.25%
Current 0.28%
Delta 0.03% Cash Generation Increased
Previous 15.95%
Current 21.01%
Delta 5.07% Growth Decreased
Previous 22.36%
Current 21.93%
Delta -0.43% Inventory Pressure Increased
Previous 8.11%
Current 8.59%
Delta 0.48% Margin Increased
Previous 45.24%
Current 49.73%
Delta 4.50% Profitability Increased
Previous 4.15%
Current 10.79%
Delta 6.64% R And D Intensity Decreased
Previous 15.17%
Current 13.26%
Delta -1.91% Sbc Intensity Decreased
Previous 6.30%
Current 5.56%
Delta -0.74% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2026
Similarity 86%
Compared 8 dimensions
Coverage 100% Growth 0.0 · Margin 30.0 · Profitability 20.0 · Sbc Intensity 0.0 · Capex Intensity 5.0 · Cash Generation 15.0 · R And D Intensity 5.0 · Inventory Pressure 0.0 Sep 30, 2021
Similarity 84%
Compared 7 dimensions
Coverage 88% Margin 5.0 · Profitability 20.0 · Sbc Intensity 20.0 · Capex Intensity 25.0 · Cash Generation 5.0 · R And D Intensity 20.0 · Inventory Pressure 5.0 Mar 31, 2021
Similarity 82%
Compared 7 dimensions
Coverage 88% Margin 15.0 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 45.0 · Cash Generation 5.0 · R And D Intensity 0.0 · Inventory Pressure 10.0 Jun 30, 2025
Similarity 70%
Compared 8 dimensions
Coverage 100% Growth 45.0 · Margin 45.0 · Profitability 30.0 · Sbc Intensity 25.0 · Capex Intensity 30.0 · Cash Generation 25.0 · R And D Intensity 0.0 · Inventory Pressure 15.0 Dec 31, 2024
Similarity 60%
Compared 8 dimensions
Coverage 100% Growth 38.2 · Margin 60.0 · Profitability 40.0 · Sbc Intensity 45.0 · Capex Intensity 30.0 · Cash Generation 55.0 · R And D Intensity 10.0 · Inventory Pressure 15.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.